MACF1 and colorectal cancer: A subsequent investigation using proteomics techniques identified MACF1 as a potential oncofetal biomarker that may be used for the diagnosis of colorectal cancer [32], while, most recently, whole-exome sequencing described MACF1 mutations in patients with endometrial cancer and renal cell carcinomas [33,34].